Access, cost, and the value of cancer care

We cannot reach the overall Biden Cancer Initiative goal of making a decade of progress in five years if any American is unable to afford the care they desperately need. This module will include segments from interviews from experts with different perspectives addressing the real challenges of cost of cancer care for patients across the United States.

Cost of Cancer Care

Access and Value of Cancer Care

Panelists

Andy Slavitt (United States of Care)
Peter Bach, MD, MAPP (Memorial Sloan Kettering Cancer Center)
Tanisha Carino (Faster Cures)
Clara Lambert (Munson Medical Center)
Robert Goldberg, PhD (Center for Medicine in the Public Interest)
David Mitchell (Patients For Affordable Drugs)

Conversation Prompts

  • What aspects of cancer are the most burdensome to patients from a cost perspective?
  • Who are the responsible entities or sectors who need to take action to change the status quo?
  • What successful models already exist from which we should be learning or borrowing?
  • What actions can we take in our community to ensure cost is not a barrier to patients receiving the best cancer care possible?

Back to the Discussion Guide Menu